BridgeBio Oncology Therapeutics Inc <BBOT.O>: Leerink Partners cuts target price to $27 from $39
BBOT•Related News
NVIDIA Corporation <NVDA.O>: Piper Sandler initiates coverage with overweight rating; target price $300
NVDA•
JPMorgan Chase announces JPST monthly cash distribution of $0.07 per unit
JPST•
SuperQ Quantum expands Waterloo lab team, hires multiple quantum hardware scientists
QUBT•
Anfield wins Utah concept approval for Velvet-Wood water treatment plan in dewatering push
AEC•
Signet Jewelers Limited <SIG.N>: Raymond James raises target price to $120 from $100
SIG•